Geode Capital Management »

Context Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 618k 2.01
2024-03-31 $140k 101k 1.38
2023-09-30 $147k 97k 1.51
2023-06-30 $172k 107k 1.60
2023-03-31 $34k 60k 0.56
2022-12-31 $40k 61k 0.65
2022-09-30 $65k 59k 1.11
2022-06-30 $124k 59k 2.11
2022-03-31 $108k 50k 2.16